Sachs Associates would like to say we enjoyed hosting you at our 7th Annual Neuroscience Innovation Forum (Sachs_NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually last week.A special thank you goes to the excellent lineup of sponsors, chairs, panelists and presenters who made such a broad and interesting programme possible and to those who participated in-person and during the virtual week.
In line with the positive sentiment around the sector, the past conference has proven to be successful in supporting our community, with 367 people from 24 countries registered and a 25% increase in meetings.
We look forward to welcoming you again to our future events!
SILVER SPONSOR:

CONTRIBUTING SPONSOR:

Presenting Companies Included:























Confirmed Keynote Speakers Included:
Harry Tracy
President, NI Research Inc.
Jonathan Javitt
CEO, NRx Pharmaceuticals, Inc.
Marc Penn
Chief Medical Officer, Keystone Bio, Inc.
Speakers and Chairs Included:
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
Daniel Lee
Partner, PJT Partners
Gregor Macdonald
VP, Head of BD & Licensing, Search & Assessment, H. Lundbeck A/S
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Jeffrey Cohen
Director of Research, Ladenburg Thalmann & Co. Inc.
Joel Sandler
Associate Partner, Ipsos Healthcare Advisory Service
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
Thomas Shrader
Managing Director & Healthcare Analyst, BTIG, LLC
Alexander Gebauer
Co-Founder & Executive Chairman, Galimedix Therapeutics, Inc.
Almira Chabi
Chief Medical Officer & Chief Development Officer, HanAll Biopharma
Andrea Malizia
CEO, IAMA Therapeutics S.r.l.
Arun Mistry
CMO, Minoryx Therapeutics S.L.
Carolina Aguilar
Co-Founder & CEO, INBRAIN Neuroelectronics
Chris Witowski
Co-Founder & CEO, Psilera Inc.
Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH
Christina Trojel-Hansen
Entrepreneur in Residence, ARCH Venture Partners
Dirk Thye
CEO & CMO, Quince Therapeutics
Doug Drysdale
CEO, Cybin Inc.
Douglas Crawford
Managing General Partner, Mission BioCapital
Gaia Skibinski
Director of Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson's Research
Ilise Lombardo
CEO, Noema Pharma AG
Ivo Staijen
Head, Public Equity, HBM Partners AG
Jeff Berkowitz
CEO, Real Endpoints
Jesús Martin-Garcia
CEO, GeNeuro SA
John Alam
Founder & CEO, CervoMed Inc.
Kabir Nath
CEO, Compass Pathways
Kees Been
CEO, KyNexis Therapeutics
Ken Mariash
CEO, Sinaptica Therapeutics, Inc.
Lisa Ricciardi
President & CEO, Cognition Therapeutics, Inc.
Lothar Krinke
CEO, Newronika S.p.A.
Lynn Durham
Founder & CEO, STALICLA SA
Marine Beurdeley
Senior Director, Global Business Development, Ipsen
Paolo Di Giorgio
Managing Director & CEO, Angelini Ventures S.p.A.
Sahil Kirpekar
Managing Partner, Lumina Life Sciences
Seth Lederman
Chairman & CEO, Tonix Pharmaceuticals Holding Corp.
Tim Luker
VP, Lilly Ventures, Eli Lilly and Company
Todd Haim
Director, Office of Strategic Extramural Programs, National Institute on Aging